SEC22A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.338600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.129800E-01
Normal-vs-Stage2
2.910200E-01
Normal-vs-Stage3
2.860200E-01
Normal-vs-Stage4
7.320600E-01
Stage1-vs-Stage2
2.454800E-01
Stage1-vs-Stage3
2.325800E-01
Stage1-vs-Stage4
7.899800E-01
Stage2-vs-Stage3
5.743600E-01
Stage2-vs-Stage4
5.582600E-01
Stage3-vs-Stage4
5.282200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.390200E-01
Normal-vs-AfricanAmerican
2.166800E-01
Normal-vs-Asian
3.014800E-01
Caucasian-vs-AfricanAmerican
7.182200E-01
Caucasian-vs-Asian
8.325400E-01
AfricanAmerican-vs-Asian
8.514800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.700800E-01
Normal-vs-Female
4.329800E-01
Male-vs-Female
2.431400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.984200E-01
Normal-vs-Age(41-60Yrs)
5.921000E-01
Normal-vs-Age(61-80Yrs)
2.266800E-01
Normal-vs-Age(81-100Yrs)
4.981600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.963600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.751600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.431600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.802600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.864600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.224000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.492000E-01
Normal-vs-Daily Drinker
1.662840E-01
Normal-vs-Weekly Drinker
3.109600E-01
Normal-vs-Occasional Drinker
9.230800E-01
Normal-vs-Social Drinker
9.732600E-01
Non Drinker-vs-Daily Drinker
8.655000E-01
Non Drinker-vs-Weekly Drinker
3.351600E-01
Non Drinker-vs-Occasional Drinker
2.989600E-02
Non Drinker-vs-Social Drinker
9.042800E-03
Daily Drinker-vs-Weekly Drinker
4.251600E-01
Daily Drinker-vs-Occasional Drinker
5.703800E-02
Daily Drinker-vs-Social Drinker
1.782210E-02
Weekly Drinker-vs-Occasional Drinker
2.710800E-01
Weekly Drinker-vs-Social Drinker
1.225760E-01
Occasional Drinker-vs-Social Drinker
8.151600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.094400E-01
Normal-vs-Grade 2
6.956000E-01
Normal-vs-Grade 3
6.134600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.363640E-01
Grade 1-vs-Grade 3
9.259100E-03
Grade 1-vs-Grade 4
5.094400E-01
Grade 2-vs-Grade 3
5.701700E-02
Grade 2-vs-Grade 4
6.956000E-01
Grade 3-vs-Grade 4
6.134600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.062600E-01
Normal-vs-NonDiabetic
3.495800E-01
Diabetic-vs-NonDiabetic
2.031200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.656200E-01
Normal-vs-NoPancreatitis
2.925200E-01
Pancreatitis-vs-NoPancreatitis
2.901800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.669600E-01
Normal-vs-N1
2.727000E-01
N0-vs-N1
5.351200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.334800E-01
Normal-vs-TP53-NonMutant
4.892000E-01
TP53-Mutant-vs-TP53-NonMutant
1.352990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
